Navigation Links
Imprimis Announces Key Leadership Appointments
Date:2/21/2013

NEW DELHI, February 21, 2013 /PRNewswire/ --

Focuses on Growth, Expansion in Sectors Like Biotechnology, Education, Retail, Corporate

Imprimis PR, one of the leading communications consultancies in India with focus on the healthcare and pharma sectors, announced key leadership appointments in New Delhi today. The firm will be undertaking a thorough forensic audit with Ernst & Young after the immediate release of the former CEO Mr. Aman Gupta and set the stage for implementing its future expansion plans.

Strengthening its leadership team, Imprimis has appointed Ms. Gracelle Gerber , a seasoned communication professional with expertise in reputation management and strategic advocacy and former SVP International at Baird's, as the CEO of Imprimis. Gerber joins Imprimis with international expertise and experience in the healthcare and pharma sector as well as industries like ICT, manufacturing, consumer, agriculture and tourism. She has worked extensively across India, Africa and Brazil. Included amongst a wide range of global FDI clients, she was the lead strategic business director for the Tata Group in Africa over the past decade, before moving to India on a full-time basis.

Ms. Nymphia Vishin, formerly the Chief Strategy Analyst at Imprimis, has been appointed the Deputy CEO of the firm. Vishin has been associated with Imprimis for over seven years, working in various leadership positions assisting key clients for their communication mandates. Her experience of working with clients, cutting across a diverse set of industries, gives her the ability to understand business complexities and successfully design communication programs that are suited to specific local needs.

Ms. Tanya Kewalramani has also been inducted as the Chief Science Communications Officer at Imprimis. Kewalramani, a Science Communications professional, holding a Masters degree from the prestigious Australian National University, will be responsible for building the biotechnology division for Imprimis in the coming years.

Dilip Cherian , Consulting Partner, Perfect Relations Group said, "As a team we are getting aggressive and looking at opportunities to scale new heights. We will be looking at new sectors and vectors of growth. Our aim is to conquer new skills of having people who have the confidence of the skills they possess so that we can look at providing services that were never before possible. Today, client needs are based on the fact that the markets are extremely competitive. Knowledge and constant practice with the much needed quality will aid in achieving far more growth and help sustaining it in the long run." 

The appointments are in line with the company's overall plans to expand presence in the Indian markets and strengthen its position across key sectors including biotechnology, education, retail and corporate other than the healthcare and pharma domain in which it's already a leader.

About Imprimis PR

Imprimis, part of the Perfect Relations Group, India's foremost independent communications firm, gained stronghold in the healthcare and pharma space over the last decade working with a slew of domestic and international pharma majors. The firm has been associated with organisations like Novartis, Lilly, Gilead, GSK, Sanofi, Apollo Hospitals, Fortis Healthcare, Jubilant Life Sciences, etc. and in recent years expanded its portfolio to include clients from education, IT/Telecom and retail sectors. Similarly, Imprimis has also been active in the CSR space working with large social institutes like the Bill & Melinda Gates Foundation, WHO, and International Aids Vaccine Initiative to name a few. For more information, visit www.imprimispr.com

Primary Media Contact: Nymphia Vishin, nvishin@imprimispr.com, 91-11-46668666


'/>"/>
SOURCE Imprimis PR
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
8. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
9. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
10. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
11. Misonix Announces New Distribution Agreement For Panama
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016  BD (Becton, Dickinson ... global medical technology company, will demonstrate an enhanced technology ... management technologies, including the company,s leading Pyxis™ and Alaris™ ... Pharmacists (ASHP) 2016 Midyear Meeting being held in ... While national data show that approximately 68 ...
(Date:12/5/2016)... Research and Markets has announced the addition of the "Global ... and Demand Forecast to 2022" report to their offering. ... , , ... market is expected to grow at a CAGR of 4.5% during ... witnessing high growth, due to growing female geriatric population and increasing ...
(Date:12/5/2016)... England , December 5, 2016 ... Transitions to Deputy Chairman   ... on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative ... has been appointed as non-executive Chairman, effective January 1 st ... of Mission Therapeutics as a non-executive Director in July 2015. ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Meeting through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on ... in 26 people will be diagnosed with epilepsy within their lifetime. With such ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... interoperability, today announced that the company will provide alerting technology to Central ... been recently awarded $1.7 million in federal funds as the sole sub-recipient ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one ... Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium at the ... techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Officer for the Florida Hospital West Florida Region. McGuinness brings experience in executive ... and engaging staff, physicians and leaders. , In her new role, that officially ...
Breaking Medicine News(10 mins):